These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37934167)

  • 1. A Survey Study of Individuals Using Hexahydrocannabinol Cannabis Products: Use Patterns and Perceived Effects.
    Ferretti ML; Gournay LR; Bingaman MG; Leen-Feldner EW
    Cannabis Cannabinoid Res; 2024 Oct; 9(5):e1385-e1394. PubMed ID: 37934167
    [No Abstract]   [Full Text] [Related]  

  • 2. Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance.
    Graziano S; Varì MR; Pichini S; Busardo FP; Cassano T; Di Trana A
    Curr Neuropharmacol; 2023; 21(12):2424-2430. PubMed ID: 37357519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review.
    Ujváry I
    Drug Test Anal; 2024 Feb; 16(2):127-161. PubMed ID: 37269160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of (9R)- and (9S)-hexahydrocannabinol (HHC) via GC-MS in serum/plasma samples from drivers suspected of cannabis consumption and immunological detection of HHC and related substances in serum, urine, and saliva.
    Höfert L; Becker S; Dreßler J; Baumann S
    Drug Test Anal; 2024 May; 16(5):489-497. PubMed ID: 37652872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies Pertaining to the Emerging Cannabinoid Hexahydrocannabinol (HHC).
    Nasrallah DJ; Garg NK
    ACS Chem Biol; 2023 Sep; 18(9):2023-2029. PubMed ID: 37578929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hexahydrocannabinol (HHC), dihydro-iso-tetrahydrocannabinol (dihydro-iso-THC) and hexahydrocannabiphorol (HHCP) in electronic cigarette cartridge products.
    Tanaka R; Kikura-Hanajiri R
    Forensic Toxicol; 2024 Jan; 42(1):71-81. PubMed ID: 37365398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC).
    Russo F; Vandelli MA; Biagini G; Schmid M; Luongo L; Perrone M; Ricciardi F; Maione S; Laganà A; Capriotti AL; Gallo A; Carbone L; Perrone E; Gigli G; Cannazza G; Citti C
    Sci Rep; 2023 Jul; 13(1):11061. PubMed ID: 37422571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexahydrocannabinol on the Light Cannabis Market: The Latest "New" Entry.
    Casati S; Rota P; Bergamaschi RF; Palmisano E; La Rocca P; Ravelli A; Angeli I; Minoli M; Roda G; Orioli M
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):622-628. PubMed ID: 36445181
    [No Abstract]   [Full Text] [Related]  

  • 9. Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC-HRMS-MS.
    Manier SK; Valdiviezo JA; Vollmer AC; Eckstein N; Meyer MR
    J Anal Toxicol; 2023 Dec; 47(9):818-825. PubMed ID: 37864499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.
    Russo EB; Cuttler C; Cooper ZD; Stueber A; Whiteley VL; Sexton M
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):706-716. PubMed ID: 34569849
    [No Abstract]   [Full Text] [Related]  

  • 11. Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs.
    Docampo-Palacios ML; Ramirez GA; Tesfatsion TT; Okhovat A; Pittiglio M; Ray KP; Cruces W
    Molecules; 2023 Sep; 28(17):. PubMed ID: 37687263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol.
    Bergeria CL; Strickland JC; Spindle TR; Kalaba M; Satyavolu PU; Feldner M; Vandrey R; Bonn-Miller M; Peters EN; Weerts E
    Exp Clin Psychopharmacol; 2023 Apr; 31(2):312-317. PubMed ID: 35467921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Consumer Attitudes Following Recent Changes in the US Hearing Health Care Market.
    Singh J; Dhar S
    JAMA Otolaryngol Head Neck Surg; 2023 Mar; 149(3):247-252. PubMed ID: 36656571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.
    Bidwell LC; Karoly HC; Torres MO; Master A; Bryan AD; Hutchison KE
    Psychopharmacology (Berl); 2022 Feb; 239(2):385-397. PubMed ID: 34708254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
    Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
    Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
    Hammond D; Goodman S
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of human hexahydrocannabinol metabolites in urine.
    Schirmer W; Auwärter V; Kaudewitz J; Schürch S; Weinmann W
    Eur J Mass Spectrom (Chichester); 2023 Oct; 29(5-6):326-337. PubMed ID: 37709263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids and bladder symptoms in multiple sclerosis.
    Kim-Fine S; Greenfield J; Chaput KH; Robert M; Metz LM
    Mult Scler Relat Disord; 2021 Sep; 54():103105. PubMed ID: 34216995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC-MS.
    Jeong M; Lee S; Seo C; Kwon E; Rho S; Cho M; Kim MY; Lee W; Lee YS; Hong J
    J Food Drug Anal; 2023 Mar; 31(1):165-176. PubMed ID: 37224558
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.